BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37335698)

  • 1. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.
    Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D
    Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Amoura Z
    Blood; 2020 Apr; 135(16):1311-1318. PubMed ID: 32107533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review.
    Garg N; Lavi ES
    J Neuroimaging; 2021 Jan; 31(1):35-44. PubMed ID: 32920940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoalphalipoproteinemia and BRAF
    Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
    Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
    Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
    Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
    Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen.
    Dai S; Su X; Liu WP; Wu Y
    Cardiovasc Pathol; 2024; 70():107625. PubMed ID: 38417471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erdheim-Chester disease.
    Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
    Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
    Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement].
    Berthe P; Rouzic N; Daelman L; Jacobzone C; Espitia A; Cohen-Aubart F; Haroche J; Émile JF; Lorleac'h A
    Rev Med Interne; 2020 Jun; 41(6):413-417. PubMed ID: 32113636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erdheim-Chester disease.
    Starkebaum G; Hendrie P
    Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101510. PubMed ID: 32305313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
    Qiao J; Ma R; Peng X; He W
    World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
    Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
    Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing
    Razanamahery J; Abdallahoui M; Chabridon G; Fromont A; Tarris G; Idbaih A; Comby PO; Godard F; Haroche J; Audia S; Bonnotte B
    Front Immunol; 2022; 13():918613. PubMed ID: 35874752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
    Dasdelen S; Büschek F
    Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.
    Salama H; Fahed Alzayed M; Alharbi KG; Khattak Z; Omer MH; Tahir L; ALhejazi A
    Am J Case Rep; 2022 Feb; 23():e935090. PubMed ID: 35171900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.